title: [A new type of ANCA in sera of patients with ulcerative colitis: effects of therapy and disease severity on serum titer].
abstract: Sera of 108 patients with chronic inflammatory bowel disease (IBD) and 13 control sera were screened for antibodies against neutrophil cytoplasmic antigens (ANCA) by an indirect immunofluorescence test. 37 out of 64 sera (58%) from patients with ulcerative colitis (UC) produced a fine granular and perinuclear ANCA staining pattern (p-ANCA) clearly different from the typically diffuse and granular cytoplasmic ANCA fluorescence (c-ANCA) seen in active Wegener's granulomatosis (WG). Only 1 of the 44 sera from patients with Crohn's disease and none of the control sera showed positive p-ANCA reactions. Only 1 of the 64 CU sera was positive for antinuclear antibodies, and another one showed a positive reaction in the anti-proteinase-3 ELISA which is specific for WG. Antibodies against myeloperoxidase were negative in the CU sera. 31 out of the 37 p-ANCA-positive sera (84%) were obtained from patients with high disease activity. p-ANCA titers became negative after long-term steroid therapy and after complete colectomy. These preliminary data suggest that ANCA screening may be of value in differentiating IBD and in monitoring disease activity and drug effects in UC patients.
authors.affiliation: Medizinische Universitätsklinik Freiburg, Abteilung Rheumatologie und Klinische Immunologie, Universität Lübeck.
authors.forename: J A
authors.initials: JA
authors.lastname: Rump
authors.forename: M
authors.initials: M
authors.lastname: Roth
authors.forename: J
authors.initials: J
authors.lastname: Schölmerich
authors.forename: R
authors.initials: R
authors.lastname: Helfesrieder
authors.forename: J
authors.initials: J
authors.lastname: Lüdemann
authors.forename: W L
authors.initials: WL
authors.lastname: Gross
authors.forename: A
authors.initials: A
authors.lastname: Rautmann
authors.forename: H H
authors.initials: HH
authors.lastname: Peter
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000276:immunology*; D003093:Colitis, Ulcerative / Q000188:drug therapy / Q000276:immunology*; D003424:Crohn Disease / Q000188:drug therapy / Q000276:immunology*; D003593:Cytoplasm / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009504:Neutrophils / Q000276:immunology*
chemical_list: D001323:Autoantibodies; D006854:Hydrocortisone; D008775:Methylprednisolone
vernacular_title: Ein neues ANCA-Muster in Seren von Patienten mit Colitis ulcerosa: Einfluss von Therapie und Krankheitsaktivität auf die Höhe der Serumtiter.